{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:00:13Z","timestamp":1792789213462,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA263196-01"],"award-info":[{"award-number":["1R01CA263196-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["175335, 707139, 707701"],"award-info":[{"award-number":["175335, 707139, 707701"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["707139, 707701"],"award-info":[{"award-number":["707139, 707701"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"name":"This study was financed by our MacFeeters-Hamilton Grant."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41591-024-03286-y","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:18:43Z","timestamp":1728368323000},"page":"116-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Prediction of brain metastasis development with DNA methylation signatures"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5418-8238","authenticated-orcid":false,"given":"Jeffrey A.","family":"Zuccato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8807-2927","authenticated-orcid":false,"given":"Yasin","family":"Mamatjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Nassiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ajisebutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-411X","authenticated-orcid":false,"given":"Ammara","family":"Muazzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1191-9579","authenticated-orcid":false,"given":"Mathew","family":"Voisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shideh","family":"Mirhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganth","family":"Suppiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7073-9041","authenticated-orcid":false,"given":"Leanne","family":"Wybenga-Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4535-5000","authenticated-orcid":false,"given":"Craig","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Saarela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9160-5405","authenticated-orcid":false,"given":"Ming S.","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kislinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-7550","authenticated-orcid":false,"given":"Kenneth D.","family":"Aldape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8696-530X","authenticated-orcid":false,"given":"Vikas","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-4502","authenticated-orcid":false,"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"3286_CR1","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto, P. W. et al. Survival in patients with brain metastases: summary report on the updated diagnosis-specific Graded Prognostic Assessment and definition of the eligibility quotient. J. Clin. Oncol. 38, 3773\u20133784 (2020).","journal-title":"J. Clin. Oncol."},{"key":"3286_CR2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","volume":"149","author":"QT Ostrom","year":"2018","unstructured":"Ostrom, Q. T., Wright, C. H. & Barnholtz-Sloan, J. S. Brain metastases: epidemiology. Handb. Clin. Neurol. 149, 27\u201342 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"3286_CR3","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis, W. D., Brambilla, E., Burke, A. P., Marx, A. & Nicholson, A. G. Introduction to the 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J. Thorac. Oncol. 10, 1240\u20131242 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"3286_CR4","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.2147\/CMAR.S222920","volume":"11","author":"G Wang","year":"2019","unstructured":"Wang, G. et al. Distribution of brain metastasis from lung cancer. Cancer Manag. Res. 11, 9331\u20139338 (2019).","journal-title":"Cancer Manag. Res."},{"key":"3286_CR5","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.4103\/2152-7806.111296","volume":"4","author":"KJ Stelzer","year":"2013","unstructured":"Stelzer, K. J. Epidemiology and prognosis of brain metastases. Surg. Neurol. Int. 4, S192\u2013S202 (2013).","journal-title":"Surg. Neurol. Int."},{"key":"3286_CR6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"EA Collisson","year":"2014","unstructured":"Collisson, E. A. et al. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543\u2013550 (2014).","journal-title":"Nature"},{"key":"3286_CR7","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/onc.2016.303","volume":"36","author":"F Chen","year":"2017","unstructured":"Chen, F. et al. Multiplatform-based molecular subtypes of non-small-cell lung cancer. Oncogene 36, 1384\u20131393 (2017).","journal-title":"Oncogene"},{"key":"3286_CR8","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1002\/cam4.3343","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai, Q. et al. Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method. Cancer Med. 9, 7488\u20137502 (2020).","journal-title":"Cancer Med."},{"key":"3286_CR9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469\u2013474 (2018).","journal-title":"Nature"},{"key":"3286_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper, D. et al. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 136, 181\u2013210 (2018).","journal-title":"Acta Neuropathol."},{"key":"3286_CR11","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-019-0766-2","volume":"11","author":"S Karimi","year":"2019","unstructured":"Karimi, S. et al. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care. Clin. Epigenetics 11, 185 (2019).","journal-title":"Clin. Epigenetics"},{"key":"3286_CR12","volume":"9","author":"JIJ Orozco","year":"2018","unstructured":"Orozco, J. I. J. et al. Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat. Commun. 9, 4627 (2018).","journal-title":"Nat. Commun."},{"key":"3286_CR13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-017-1678-x","volume":"133","author":"A Olar","year":"2017","unstructured":"Olar, A. et al. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol. 133, 431\u2013444 (2017).","journal-title":"Acta Neuropathol."},{"key":"3286_CR14","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/neuonc\/noz061","volume":"21","author":"F Nassiri","year":"2019","unstructured":"Nassiri, F. et al. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro. Oncol. 21, 901\u2013910 (2019).","journal-title":"Neuro. Oncol."},{"key":"3286_CR15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/neuonc\/noab235","volume":"24","author":"JA Zuccato","year":"2022","unstructured":"Zuccato, J. A. et al. DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma. Neuro. Oncol. 24, 442\u2013454 (2022).","journal-title":"Neuro. Oncol."},{"key":"3286_CR16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen, S. Y. et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563, 579\u2013583 (2018).","journal-title":"Nature"},{"key":"3286_CR17","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-020-0932-2","volume":"26","author":"F Nassiri","year":"2020","unstructured":"Nassiri, F. et al. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes. Nat. Med. 26, 1044\u20131047 (2020).","journal-title":"Nat. Med."},{"key":"3286_CR18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41591-020-0933-1","volume":"26","author":"PV Nuzzo","year":"2020","unstructured":"Nuzzo, P. V. et al. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes. Nat. Med. 26, 1041\u20131043 (2020).","journal-title":"Nat. Med."},{"key":"3286_CR19","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41596-019-0202-2","volume":"14","author":"SY Shen","year":"2019","unstructured":"Shen, S. Y., Burgener, J. M., Bratman, S. V. & De Carvalho, D. D. Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA. Nat. Protoc. 14, 2749\u20132780 (2019).","journal-title":"Nat. Protoc."},{"key":"3286_CR20","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U","volume":"78","author":"ES Nussbaum","year":"1996","unstructured":"Nussbaum, E. S., Djalilian, H. R., Cho, K. H. & Hall, W. A. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 78, 1781\u20131788 (1996).","journal-title":"Cancer"},{"key":"3286_CR21","doi-asserted-by":"crossref","first-page":"S586","DOI":"10.1016\/S0959-8049(16)31622-7","volume":"3","author":"P Brastianos","year":"2015","unstructured":"Brastianos, P. et al. Genomic characterization of brain metastases and paired primary tumors reveals branched evolution and potential therapeutic targets. Eur. J. Cancer 3, S586 (2015).","journal-title":"Eur. J. Cancer"},{"key":"3286_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100741","volume":"8","author":"N Woldmar","year":"2023","unstructured":"Woldmar, N. et al. Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases. ESMO Open 8, 100741 (2023).","journal-title":"ESMO Open"},{"key":"3286_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","volume":"86","author":"M Riihim\u00e4ki","year":"2014","unstructured":"Riihim\u00e4ki, M. et al. Metastatic sites and survival in lung cancer. Lung Cancer 86, 78\u201384 (2014).","journal-title":"Lung Cancer"},{"key":"3286_CR24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/cncr.10687","volume":"95","author":"GL Ceresoli","year":"2002","unstructured":"Ceresoli, G. L. et al. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer 95, 605\u2013612 (2002).","journal-title":"Cancer"},{"key":"3286_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98847-3","volume":"11","author":"M Stankiewicz","year":"2021","unstructured":"Stankiewicz, M., Tomasik, B. & Blamek, S. A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases. Sci. Rep. 11, 20347 (2021).","journal-title":"Sci. Rep."},{"key":"3286_CR26","volume":"12","author":"H Hu","year":"2021","unstructured":"Hu, H. et al. Brain metastases status and immunotherapy efficacy in advanced lung cancer: a systematic review and meta-analysis. Front. Immunol. 12, 669398 (2021).","journal-title":"Front. Immunol."},{"key":"3286_CR27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jtho.2021.04.014","volume":"16","author":"V Teixeira Loiola de Alencar","year":"2021","unstructured":"Teixeira Loiola de Alencar, V., Guedes Camandaroba, M. P., Pirolli, R., Fogassa, C. A. Z. & Cordeiro de Lima, V. C. Immunotherapy as single treatment for patients with NSCLC with brain metastases: a systematic review and meta-analysis\u2014the META-L-BRAIN Study. J. Thorac. Oncol. 16, 1379\u20131391 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"3286_CR28","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde, P. M. et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N. Engl. J. Med. 386, 1973\u20131985 (2022).","journal-title":"N. Engl. J. Med."},{"key":"3286_CR29","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines: Central Nervous System Cancers (v.2) https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1425 (2021)."},{"key":"3286_CR30","volume":"11","author":"AC Tan","year":"2022","unstructured":"Tan, A. C. et al. Clinical trial eligibility criteria and recently approved cancer therapies for patients with brain metastases. Front. Oncol. 11, 780379 (2022).","journal-title":"Front. Oncol."},{"key":"3286_CR31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.hoc.2021.08.004","volume":"36","author":"E Nieblas-Bedolla","year":"2022","unstructured":"Nieblas-Bedolla, E., Zuccato, J., Kluger, H., Zadeh, G. & Brastianos, P. K. Central nervous system metastases. Hematol. Oncol. Clin. North Am. 36, 161\u2013188 (2022).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"3286_CR32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio, F. et al. A landscape of pharmacogenomic interactions in cancer. Cell 166, 740\u2013754 (2016).","journal-title":"Cell"},{"key":"3286_CR33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette, M. A. et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200\u2013225 (2020).","journal-title":"Cell"},{"key":"3286_CR34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","volume":"489","author":"PS Hammerman","year":"2012","unstructured":"Hammerman, P. S. et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519\u2013525 (2012).","journal-title":"Nature"},{"key":"3286_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2014.08.011","volume":"72","author":"TJ Morris","year":"2015","unstructured":"Morris, T. J. & Beck, S. Analysis pipelines and packages for Infinium HumanMethylation450 BeadChip (450k) data. Methods 72, 3\u20138 (2015).","journal-title":"Methods"},{"key":"3286_CR36","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-017-0333-7","volume":"9","author":"T Kling","year":"2017","unstructured":"Kling, T., Wenger, A., Beck, S. & Car\u00e9n, H. Validation of the MethylationEPIC BeadChip for fresh-frozen and formalin-fixed paraffin-embedded tumours. Clin. Epigenetics 9, 33 (2017).","journal-title":"Clin. Epigenetics"},{"key":"3286_CR37","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3286_CR38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"3286_CR39","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"3286_CR40","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jtho.2021.02.023","volume":"16","author":"W-F Tang","year":"2021","unstructured":"Tang, W.-F. et al. Timing and origins of local and distant metastases in lung cancer. J. Thorac. Oncol. 16, 1136\u20131148 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"3286_CR41","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban, R. et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun. Signal. 18, 59 (2020).","journal-title":"Cell Commun. Signal."},{"key":"3286_CR42","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy, A. et al. Pan-cancer deconvolution of tumour composition using DNA methylation. Nat. Commun. 9, 3220 (2018).","journal-title":"Nat. Commun."},{"key":"3286_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18070-y","volume":"11","author":"Y Grabovska","year":"2020","unstructured":"Grabovska, Y. et al. Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity. Nat. Commun. 11, 4324 (2020).","journal-title":"Nat. Commun."},{"key":"3286_CR44","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1158\/1078-0432.CCR-22-0391","volume":"28","author":"K Guidry","year":"2022","unstructured":"Guidry, K. et al. DNA methylation profiling identifies subgroups of lung adenocarcinoma with distinct immune cell composition, DNA methylation age, and clinical outcome. Clin. Cancer Res. 28, 3824\u20133835 (2022).","journal-title":"Clin. Cancer Res."},{"key":"3286_CR45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/1541-7786.MCR-22-0163","volume":"21","author":"S Mirhadi","year":"2023","unstructured":"Mirhadi, S. et al. Mitochondrial aconitase ACO2 links iron homeostasis with tumorigenicity in non-small cell lung cancer. Mol. Cancer Res. 21, 36\u201350 (2023).","journal-title":"Mol. Cancer Res."},{"key":"3286_CR46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/pmic.201300382","volume":"14","author":"W Zhang","year":"2014","unstructured":"Zhang, W. et al. Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches. Proteomics 14, 795\u2013803 (2014).","journal-title":"Proteomics"},{"key":"3286_CR47","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1021\/acs.jproteome.9b00082","volume":"18","author":"JR Krieger","year":"2019","unstructured":"Krieger, J. R. et al. Evosep One enables robust deep proteome coverage using tandem mass tags while significantly reducing instrument time. J. Proteome Res. 18, 2346\u20132353 (2019).","journal-title":"J. Proteome Res."},{"key":"3286_CR48","doi-asserted-by":"crossref","first-page":"100279","DOI":"10.1016\/j.mcpro.2022.100279","volume":"21","author":"P Skowronek","year":"2022","unstructured":"Skowronek, P. et al. Rapid and in-depth coverage of the (phospho-)proteome with deep libraries and optimal window design for dia-PASEF. Mol. Cell. Proteomics 21, 100279 (2022).","journal-title":"Mol. Cell. Proteomics"},{"key":"3286_CR49","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31492-0","volume":"13","author":"V Demichev","year":"2022","unstructured":"Demichev, V. et al. dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts. Nat. Commun. 13, 3944 (2022).","journal-title":"Nat. Commun."},{"key":"3286_CR50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"3286_CR51","unstructured":"Chakravarthy, A. Reproducibility archive for MeDIP analyses of plasma DNA from brain tumour patients. Zenodo https:\/\/zenodo.org\/records\/3715312 (2020)."},{"key":"3286_CR52","unstructured":"Zuccato, J., Patil, V. & Zadeh, G. Predictive modelling of brain metastasis risk and non-invasive biomarker detection using DNA methylation signatures. Zenodo https:\/\/zenodo.org\/records\/7338401 (2022)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03286-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T18:05:21Z","timestamp":1737482721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03286-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3286"],"URL":"https:\/\/doi.org\/10.1038\/s41591-024-03286-y","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"23 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}